ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Ioannis Katsoulis, Axel Svedbom, Larushka Mellor and Örjan Åkerborg consider trends and strategies to drive uptake of biosimilars in the UK.
The Path to Successful HTA Submissions
Manpreet Sidhu discusses the factors that are key to success in achieving favourable HTA reviews around the world in this Pharmafocus article.
Assessing The Impact Of MDR & IVDR On Patients
This article explores the need to assess the impact of MDR/IVDR on patients after the new medical device regulation is established.
Standardized eCOA Questionnaire Library Will Speed Study Start-Up
Read about ICON’s Mapi Research Trust & Medidata's plan to develop a global library of pre-configured, pre-approved eCOA questionnaires to accelerate study start-up.
Shock to the System: An Examination of Neurostim Technologies
Learn how targeted electrical nerve stimulation technology can aid in chronic disease management by improving on current treatment methods.
Tom O'Leary considers how the Internet of Medical Things (loMT) is evolving the patient role in pharma.
Regulatory Bottlenecks Mean EU Clinicians & Patients Could Lose Access to Medical Devices Under New Rules
A press release on ICON’s upcoming presentation at The Medtech Conference 2019, ‘MDR/IVDR - What now?'
Making a Difference
ICON has been recognised for making a difference in Conversis' recent article.
Hasta la vista, maybe? Terminating the Hollywood view of AI in pharma
Read Pharmaceutical Market Europe (PME)'s recent article featuring commentary from ICON's Tom O’Leary on the use of AI in the pharmaceutical sector.
The Evolution of Real World Studies
Read PME's recent article featuring commentary from ICON expert Bill Row on the evolution of real world studies.